Skip to content

Scholar Rock SRRK RD Expense Srk439 — Research And Development Expense

Other product segments

Apitegromab
$20.26M
Early Research
$1.21M-16.8%
RD Expense Srk181
$36K

Similar metrics at other companies

Tango Therapeutics logo
TNGXPersonnel-Related Expenses-RD — Research And Development Expense
$12.93M-6.6%
Tango Therapeutics logo
TNGXFacilities And Other Related Expenses-RD — Research And Development Expense
$4.34M-20.6%
Tango Therapeutics logo
TNGXDiscovery Direct Program Expenses-RD — Research And Development Expense
$1.87M-60.0%
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Dianthus Therapeutics logo
DNTHOther Costs — Research And Development Expense
$1.49M+25.5%
Dianthus Therapeutics logo
DNTHPersonnel And Related Costs — Research And Development Expense
$8.64M+47.7%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's rd expense srk439 — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's RD expense srk439 — research and development expense?
Scholar Rock (SRRK) reported RD expense srk439 — research and development expense of $1.76M in Q1 2026.
How has Scholar Rock's RD expense srk439 — research and development expense changed year-over-year?
Scholar Rock's RD expense srk439 — research and development expense decreased by 58.9% year-over-year, from $4.28M to $1.76M.
What does RD expense srk439 — research and development expense mean?
This metric represents the total operating costs directly attributable to the research and development activities for a specific therapeutic candidate or clinical program. It captures the investment in clinical trials, preclinical studies, and manufacturing process development required to advance the asset through the regulatory pipeline. Monitoring this expenditure provides insight into the company's capital allocation strategy and the pace of development for its core pipeline assets.